Answers are grounded in this paper and cite their sources.
In addition to the decrease in circulating CD4+ T cells and CD19+ B cells, our findings highlight additional immunoregulatory mechanisms induced by fingolimod.
No takes yet. Share an insight, caveat, or question.
Muls et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: